C. Schaake-Koning

发表

The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC Radiotherapy and Lung Cancer Cooperative Groups.

H. Bartelink, N. van Zandwijk, C. Schaake-Koning, 1991, European journal of cancer.

Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.

H. Bartelink, O. Dalesio, B. Maat, 1992, The New England journal of medicine.

Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer.

H. Bartelink, J. Benraadt, D. González González, 1996, European journal of cancer.

Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups.

O. Dalesio, B. Maat, P. van Houtte, 1994, Lung cancer.

Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups.

H. Bartelink, O. Dalesio, B. Maat, 1990, International journal of radiation oncology, biology, physics.

Radiotherapy and cis-diammine dichloroplatinum (II) as a combined treatment modality for inoperable non-small cell lung cancer: a dose finding study.

H. Bartelink, N. van Zandwijk, C. Schaake-Koning, 1986, International journal of radiation oncology, biology, physics.

Four patients with recurrences of Hodgkin's disease after 15 years or more.

P. van Heerde, R. Somers, C. Schaake-Koning, 1994, European journal of cancer.

Radiotherapy Combined with Daily or Weekly cis-Diammine Dichloroplatinum (II) in Inoperable Non-Metastasized Non-Small Cell Lung Cancer: A Toxicity Report of the Randomized Phase III Study of the EORTC Lung Cancer Cooperative and Radiotherapy Cooperative Groups

H. Bartelink, O. Dalesio, B. Maat, 1991 .

High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer.

G. Sutedja, N. van Zandwijk, C. Schaake-Koning, 1992, International journal of radiation oncology, biology, physics.

Radiotherapy combined with low-dose cisplatin; results of the EORTC 08844 phase III study by the EORTC Radiotherapy and Lung Cancer Cooperative Groups

H. Bartelink, O. Dalesio, B. Maat, 1993 .

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study.

E. Engelsman, C. Schaake-Koning, G. Hart, 1985, International journal of radiation oncology, biology, physics.

Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy.

D. González González, C. Schaake-Koning, G. Hart, 1983, International journal of radiation oncology, biology, physics.

The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.

S. Rodenhuis, J. Baars, D. Richel, 1996, European journal of cancer.

Radiotherapy in non-small cell lung cancer: optimal doses and schedules.

C. Schaake-Koning, 1995, Lung cancer.

Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.

J. Peterse, S. Rodenhuis, D. Richel, 1993, Annals of Oncology.